Abstract
Despite remarkable improvement of surgical and cardiopulmonary bypass technique, nonsurgical bleeding is still a serious complication following cardiac surgery. As nonthrombotic material or an ideal anticoagulant preventing contact activation of the blood has not been found, a method to reduce'whole body inflammatory response' and postoperative bleeding is an appealing option to improve the postoperative status of patients undergoing cardiac surgery. Discussing the rationale behind preoperative leucocyte-plasmapheresis the possible benefits of this new method are explained. Reviewing the literature, possibilities of future development is outlined.
Get full access to this article
View all access options for this article.
